Cyient Limited (CYIENT) AI Stock Analysis

• Market Cap: ₹128.54B
• Dividend Yield: 2.7%
• Average Volume (3M): 28.76K
• Price to Earnings (P/E): 22.2
• Beta (1Y): 1.59
• Revenue Growth: 1.68%
• EPS Growth: -12.95%
• Country: IN
• Employees: 12,733
• Sector: Technology
• Sector Strength: 88
• Industry: Conglomerates
• EPS (TTM): 11.53
• Shares Outstanding: 111,090,380
• 10 Day Avg. Volume: 49,740
• 30 Day Avg. Volume: 28,762
• PEG Ratio: -2.20
• Price to Book (P/B): 2.58
• Price to Sales (P/S): 1.86
• P/FCF Ratio: 19.97
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,420.00
• Price Target Upside: 27.78% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 73 Outperform
• Price Target: ₹1,313.00 ▲(18.16% Upside)

Cyient Limited's strong financial performance, characterized by robust revenue growth and operational efficiency, is the primary driver of its stock score. The technical analysis indicates neutral to slightly positive momentum, while the valuation suggests moderate attractiveness with a reasonable dividend yield. The absence of significant earnings call insights or corporate events means these factors do not influence the score.

Cyient Limited Business Overview & Revenue Model

Company Description

Cyient Limited (CYIENT) is a global engineering and technology solutions company headquartered in India. It specializes in providing solutions across various sectors, including aerospace, defense, healthcare, telecommunications, and transportation. The company offers a range of services such as product engineering, data analytics, digital transformation, and geospatial services, enabling clients to enhance their operational efficiency and accelerate innovation.

How the Company Makes Money

Cyient generates revenue primarily through its engineering services and solutions, which include product development, design, and manufacturing support. The company operates on a project-based revenue model, where it engages in long-term contracts and partnerships with clients in various sectors. Key revenue streams come from its aerospace and defense segment, which includes services like aircraft design and maintenance, and the healthcare segment, which focuses on medical device engineering. Additionally, Cyient has formed significant partnerships with leading companies and government agencies, which provide a steady stream of business and enhance its market presence. The company's emphasis on digital services and solutions, particularly in data analytics and IoT, further diversifies its revenue sources and contributes to sustained growth.

Cyient Limited Financial Statement Overview

Summary

Cyient Limited showcases strong financial performance with consistent revenue growth and operational efficiency. The balance sheet highlights reduced leverage and stability, while cash flows remain robust, supporting ongoing operations and investment capacity. However, slight pressure on net profit margins and a declining return on equity suggest potential areas for improvement.

Income Statement

Cyient Limited demonstrates robust revenue growth with a 20.71% increase from 2023 to 2024 and a 2.99% increase from 2024 to 2025. The gross profit margin remains strong at 34.39% in 2025, showcasing effective cost management. However, the net profit margin slightly decreased to 8.37% in 2025 from 9.55% in 2024, indicating some pressure on profitability. The EBIT margin is notably high at 34.39% in 2025, pointing to operational efficiency. Overall, the income statement reflects strong growth and profitability, albeit with slight pressure on net margins.

Balance Sheet

The company maintains a healthy balance sheet with a decreasing debt-to-equity ratio from 0.18 in 2024 to 0.10 in 2025, indicating reduced leverage. Stockholders' equity has grown significantly, reflecting strong financial health. The equity ratio improved to 68.99% in 2025, underscoring the company's stability. However, the high proportion of equity compared to total assets may limit financial flexibility, and the declining return on equity from 16.03% in 2024 to 11.60% in 2025 suggests a dip in shareholder returns.

Cash Flow

Cyient Limited displays strong cash flow management with a free cash flow growth rate of 7.04% from 2024 to 2025. The operating cash flow to net income ratio is 1.28, indicating efficient cash generation relative to net income. Additionally, the free cash flow to net income ratio of 1.11 further highlights the company's ability to convert earnings into cash. Despite strong cash flows, the operating cash flow saw a modest increase year-on-year, suggesting limited growth in operational cash generation.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	73.97B	73.60B	71.47B	60.16B	45.34B	41.32B
Gross Profit	23.93B	14.88B	24.24B	14.21B	18.82B	16.35B
EBITDA	12.09B	11.43B	13.00B	10.23B	9.25B	7.14B
Net Income	6.26B	6.16B	6.83B	5.14B	5.22B	3.64B
Balance Sheet
Total Assets	79.95B	76.95B	70.04B	65.48B	47.87B	44.93B
Cash, Cash Equivalents and Short-Term Investments	17.41B	14.68B	10.59B	7.91B	13.00B	14.38B
Total Debt	5.65B	5.24B	7.88B	12.18B	5.73B	5.77B
Total Liabilities	20.01B	19.34B	24.47B	30.85B	16.74B	15.39B
Stockholders Equity	59.95B	53.09B	42.58B	34.67B	31.17B	29.57B
Cash Flow
Free Cash Flow	0.00	6.86B	6.41B	4.86B	5.70B	7.57B
Operating Cash Flow	0.00	7.90B	7.26B	5.54B	6.34B	8.56B
Investing Cash Flow	0.00	-1.45B	-5.33B	-10.33B	-3.82B	-1.01B
Financing Cash Flow	0.00	-582.00M	-2.66B	-1.09B	-5.45B	-2.11B

Cyient Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1111.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CYIENT, the sentiment is Negative. The current price of 1111.25 is below the 20-day moving average (MA) of 1163.71, below the 50-day MA of 1172.12, and below the 200-day MA of 1248.40, indicating a bearish trend. The MACD of -6.83 indicates Positive momentum. The RSI at 35.19 is Neutral, neither overbought nor oversold. The STOCH value of 8.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CYIENT.

Cyient Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MSTCLTD	77 Outperform	₹38.66B	9.09	―	8.49%	-58.05%	97.11%
CYIENT	73 Outperform	₹128.54B	22.20	―	2.70%	1.68%	-12.95%
NAVA	69 Neutral	₹171.99B	16.68	―	1.39%	1.03%	-17.68%
BEML	68 Neutral	₹178.48B	59.72	―	0.26%	-1.31%	3.61%
CARBORUNIV	65 Neutral	₹170.49B	85.10	―	0.44%	4.51%	-57.87%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

Cyient Limited Corporate Events

Cyient Limited Publishes Q3 2025 Financial Results

Cyient Limited announced the publication of its financial results for the quarter ending September 30, 2025, in major newspapers. This announcement is part of the company’s compliance with SEBI regulations, ensuring transparency and timely disclosure of financial performance. The publication of these results is crucial for stakeholders to assess the company’s financial health and strategic direction.

Cyient Limited Allots Shares to Associates

Cyient Limited has announced the allotment of 3,244 equity shares to its associates following the exercise of stock options under the ASOP 2015 and ARSUS 2020 schemes. This move reflects the company’s ongoing commitment to rewarding its employees and enhancing stakeholder value, potentially strengthening its position in the competitive technology and engineering services market.

Cyient Limited Announces New Board Appointments and Leadership Continuity

Cyient Limited announced the results of a postal ballot where shareholders approved the appointment of Mr. P.R. Ramesh and Prof. Madan Pillutla as Non-Executive, Independent Directors, and the continuation of Mr. B.V.R. Mohan Reddy as a Non-Executive, Non-Independent Director despite his age. This decision, passed with a significant majority through remote e-voting, highlights the company’s commitment to maintaining experienced leadership, which could strengthen its governance and strategic direction.

Cyient Limited Appoints New Chief Marketing Officer

Cyient Limited has announced the appointment of Mr. Utkarsh Srivastav as the new Chief Marketing Officer, effective October 3, 2025. With over 18 years of experience in B2B marketing, Utkarsh is expected to drive brand recognition and revenue growth, leveraging his expertise in creating compelling brand narratives and executing strategic go-to-market plans. His previous roles at L&T Technology Services and HCL Tech highlight his capability in brand positioning and global marketing initiatives, which are anticipated to strengthen Cyient’s market positioning and stakeholder value.

Cyient Limited to Host Q2 FY26 Earnings Conference Call

Cyient Limited has announced that it will host an earnings conference call on October 16, 2025, to discuss the financial results for the second quarter ended September 30, 2025. The call will be conducted by the senior management team and will provide insights into the company’s performance and strategic direction, potentially impacting stakeholders and industry positioning.

Cyient Limited Unfazed by H1B Visa Fee Hike

Cyient Limited has announced that the recent US Government’s decision to impose a one-time fee of US$ 100,000 for each new H1B visa petition will not have a material impact on its financials for FY26 and the immediate term. In FY25, Cyient had six employees on H1B visas, and the company remains committed to its global engineering and technology enterprise philosophy, which underpins its market leadership and risk management in a rapidly changing world.

Cyient Limited Strengthens Leadership with New Independent Directors

Cyient Limited has announced the appointment of Mr. P.R. Ramesh and Mr. Madan Pillutla as Non-Executive Independent Directors, effective from August 18, 2025, for a term of three years. This strategic move is expected to strengthen the company’s governance framework and enhance its leadership capabilities, potentially impacting its market positioning positively by bringing in experienced professionals with a wealth of industry knowledge.